Roche Holding AG

LSE:0QQ6.LHealthcare

——At close · Market cap —

0QQ6.L · Income statement · TradingHolo

CHF billions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Revenue	58.3	62.8	63.3	60.4	60.5	61.5	+1.7%
Cost of revenue	16.4	19.7	18.8	15.6	16.0	16.3	+1.6%
Gross profit	42.0	43.1	44.4	44.8	44.5	45.2	+1.7%
Research & development	12.2	13.7	14.1	14.2	12.6	13.4	+6.3%
Selling, general & administrative	11.8	11.9	12.0	13.5	13.4	15.2	+12.8%
Selling & marketing	9.4	9.5	0.0	0.0	0.0	0.0	—
Operating expenses	24.2	25.8	26.3	29.4	26.2	26.0	−1.0%
Operating income	17.7	17.3	18.2	15.4	18.2	19.3	+5.7%
Interest expense	0.4	0.3	0.6	0.8	1.2	1.3	+8.1%
Interest income	0.0	0.3	0.6	0.6	0.0	0.0	—
Other income / expense	0.2	0.1	(1.8)	(1.3)	(6.4)	(2.3)	+64.2%
Pre-tax income	18.0	17.4	16.4	14.1	11.8	17.0	+43.4%
Income tax	2.9	2.5	2.8	1.7	2.6	3.2	+21.8%
Net income	14.3	13.9	12.4	11.5	8.3	12.9	+55.6%
Discontinued operations	0.0	0.0	0.0	0.0	0.0	0.0	—
Other net income adjustments	0.0	0.0	0.0	0.0	(0.0)	0.0	+100.0%
EPS, basic (per share)	16.72	16.39	15.53	14.39	10.39	15.92	+53.2%
EPS, diluted (per share)	16.52	16.20	15.53	14.30	10.32	16.04	+55.4%
EBITDA	23.0	22.2	20.8	18.4	16.5	22.7	+37.2%
Depreciation & amortization	4.6	4.4	3.8	3.5	3.4	3.4	−1.1%
Weighted average shares (shares)	855,000,000	850,000,000	800,000,000	799,000,000	797,000,000	802,817,000	+0.7%
Weighted average diluted shares (shares)	865,000,000	860,000,000	800,000,000	804,000,000	802,000,000	803,000,000	+0.1%
Gross margin	72.0%	68.6%	70.2%	74.2%	73.5%	73.5%	+0.0 pts
Operating margin	30.4%	27.5%	28.7%	25.5%	30.1%	31.3%	+1.2 pts
Net margin	24.5%	22.2%	19.6%	19.0%	13.7%	20.9%	+7.3 pts

CHF billionsUpdated 31 Dec 2025 ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.